Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis

(1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this <i>gender gap</i> is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female a...

Full description

Bibliographic Details
Main Authors: Christiane Gärtner, Jörg Fallmann, Peter F. Stadler, Thorsten Kaiser, Sarah J. Berkemer
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/13/6/924
Description
Summary:(1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this <i>gender gap</i> is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female and male CF patients are analyzed in order to determine the pathways related to sex-biased genes and assess their potential influence on sex-specific effects in CF patients. (3) Results: We identify sex-biased genes in female and male CF patients and provide explanations for some sex-specific differences at the molecular level. (4) Conclusion: Genes in key pathways associated with CF are differentially expressed between sexes, and thus may account for the gender gap in morbidity and mortality in CF.
ISSN:2075-4426